Den här översättningen är inte klar ännu. Den här sidan är just nu på engelska.

Gå till den engelska sidan

Cure My Disease

Don't miss your cure!

 Log in / Sign up

Hair loss drug shows promise in major new trial

NCT ID NCT07023302

Recruiting now Disease control Sponsor: AbbVie Source: ClinicalTrials.gov ↗

First seen Jan 04, 2026 · Last updated May 25, 2026 · Updated 20 times

Summary

This study tests an oral drug called upadacitinib for people with severe alopecia areata, an autoimmune condition that causes patchy or total scalp hair loss. About 123 adults and teens in Japan with at least 25% hair loss will take either the drug or a placebo daily for up to 2 years. The goal is to see if the drug can regrow hair and improve quality of life, while monitoring side effects.

Disclaimer Read more

This is a summary of the original study . Summaries may miss details or leave out important information. Before applying or accepting participation, make sure you have read and understood the full study. Curemydisease.com takes no responsibility whatsoever for anything missed, misunderstood, or acted upon as a result of our summary — we know it does not capture everything.

Get updates

Get notified about this study

Sign up to get updates when this study changes or when new studies for ALOPECIA AREATA are added.

Vår säkerhetsrekommendation!

Genom att skicka in godkänner du våra Användarvillkor

Contacts and locations

Study contacts

  • Contact

    Phone: •••-•••-•••• Email: •••••@•••••

Locations

  • Hamamatsu University Hospital /ID# 274639

    RECRUITING

    Hamamatsu, Shizuoka, 431-3192, Japan

  • Juntendo Tokyo Koto Geriatric Medical Center /ID# 275424

    RECRUITING

    Tokyo, 136-0075, Japan

  • Kanazawa Medical University Hospital /ID# 275521

    RECRUITING

    Kahoku-gun, Ishikawa-ken, 920-0265, Japan

  • Keio University Hospital /ID# 275640

    RECRUITING

    Shinjuku-ku, Tokyo, 160-8582, Japan

  • Kurume University Hospital /ID# 275519

    RECRUITING

    Kurume-shi, Fukuoka, 830-0011, Japan

  • Kyorin University Hospital /ID# 274882

    RECRUITING

    Mitaka-shi, Tokyo, 181-8611, Japan

  • Nagomi Dermatology Clinic /ID# 275418

    RECRUITING

    Ebina-shi, Kanagawa, 243-0432, Japan

  • Nagoya City University Hospital /ID# 275409

    RECRUITING

    Nagoya, Aichi-ken, 467-8602, Japan

  • Niigata University Medical & Dental Hospital /ID# 274775

    RECRUITING

    Niigata, Niigata, 951-8520, Japan

  • Osaka Metropolitan University Hospital /ID# 274956

    RECRUITING

    Osaka, Osaka, 545-8586, Japan

  • Rifu Dermatology Allergy Clinic /ID# 274875

    RECRUITING

    Miyagi-gun, Miyagi, 981-0112, Japan

  • Shinsaibashi Inui Dermatology Clinic /ID# 274851

    RECRUITING

    Osaka, Osaka, 542-0081, Japan

  • Tohoku University Hospital /ID# 274931

    RECRUITING

    Sendai, Miyagi, 980-8574, Japan

  • Tokyo Medical University Hospital /ID# 274844

    RECRUITING

    Shinjuku-ku, Tokyo, 160-0023, Japan

  • Yamaguchi University Hospital /ID# 274638

    RECRUITING

    Ube, Yamaguchi, 755-8505, Japan

Conditions

Explore the condition pages connected to this study.

ALOPECIA AREATA